Deciphering the role of nanocarrier-based nucleic acid delivery to the brain for the management of neurodegenerative disorders DOI

Subham Panigrahy,

Anupama Sikder,

Etikala Amulya

et al.

Journal of Drug Delivery Science and Technology, Journal Year: 2023, Volume and Issue: 92, P. 105325 - 105325

Published: Dec. 30, 2023

Language: Английский

Insight into Steroid-Induced ONFH: The Molecular Mechanism and Function of Epigenetic Modification in Mesenchymal Stem Cells DOI Creative Commons
Chengxiong Huang,

Liming Qing,

Xiao Yu

et al.

Biomolecules, Journal Year: 2023, Volume and Issue: 14(1), P. 4 - 4

Published: Dec. 20, 2023

Osteonecrosis of the femoral head (ONFH) is a common refractory orthopedic disease, which one causes hip pain and dysfunction. ONFH has very high disability rate, associated with heavy burden to patients, families, society. The pathogenesis not completely clear. At present, it believed that mainly includes coagulation dysfunction, abnormal lipid metabolism, an imbalance osteogenic/adipogenic differentiation, poor vascularization repair. prevention treatment always been great challenge for clinical surgeons. However, recent studies have emphasized use mesenchymal stem cells (MSCs) treat steroid-induced (SONFH) promising therapy. This review focuses on role molecular mechanism epigenetic regulation in progress MSCs SONFH, discusses significance latest research SONFH from perspective epigenetics.

Language: Английский

Citations

6

A Genome-wide CRISPR screen unveils WDR91 protein as a promoter of productive ASO activity DOI

Grégory Menchon,

Aris Gaci,

Antti Matvere

et al.

bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown

Published: March 30, 2024

Antisense oligonucleotides (ASOs) belong to promising therapeutic molecules for the treatment of neurologic, muscular and metabolic disorders. Several ASOs have been approved so far more than a hundred clinical trials are currently underway covering dozen areas including cancer. Yet, mechanisms internalization, cell trafficking action these remain poorly understood. Moreover, with only small fraction reaching correct cellular compartment following systemic delivery, majority targeted diseases requires recurrent injections ASOs. A deeper understanding would guide improvement their potency thus, reduce amount delivered potential side-effects. Here, using CRISPR screen, we investigated intracellular proteins involved in efficiency whole genome approach identified several regulators which could significantly impact melanoma cells. From proteins, validated WD Repeat Domain 91 (WDR91), regulator endosomal maturation, as modulator whose depletion inhibits ASO productive activity. This study provides first list modulators biologically relevant functional assay estimate role proteins. In conclusion, data lead better favoring uptake or improved escape

Language: Английский

Citations

1

Mechanistic Insights into the Tools for Intracellular Protein Delivery DOI Creative Commons
Jingwen Xie, Jiajia Xiang, Youqing Shen

et al.

Chem & Bio Engineering, Journal Year: 2024, Volume and Issue: 2(3), P. 132 - 155

Published: Dec. 23, 2024

Proteins are an important therapeutic modality in modern medicine. However, their inherent inability to traverse cell membranes essentially limits application extracellular targets. Recent advances intracellular protein delivery have enabled access traditionally "undruggable" targets and paved the way precisely modulate cellular functions. This Review provides a comprehensive examination of key mechanisms emerging technologies that facilitate transport functional proteins across membranes. Delivery methods categorized into physical, chemical, biological approaches, each with distinct advantages limitations. Physical enable direct entry but often pose challenges related invasiveness technical complexity. Chemical strategies offer customizable solutions enhanced control over targeting uptake, yet may face issues cytotoxicity scalability. Biological approaches leverage naturally occurring processes achieve efficient transport, though regulatory production consistency remain hurdles. By highlighting recent advancements, challenges, opportunities within approach, this review underscores potential unlock new pathways transform drug development paradigms.

Language: Английский

Citations

1

Weaving the gates of life: Pioneering a new era in oral gene delivery with metal-organic frameworks DOI
Min Jiang, Guohui Zhang, Qin Zeng

et al.

Chemical Engineering Journal, Journal Year: 2024, Volume and Issue: 503, P. 158522 - 158522

Published: Dec. 10, 2024

Language: Английский

Citations

1

Deciphering the role of nanocarrier-based nucleic acid delivery to the brain for the management of neurodegenerative disorders DOI

Subham Panigrahy,

Anupama Sikder,

Etikala Amulya

et al.

Journal of Drug Delivery Science and Technology, Journal Year: 2023, Volume and Issue: 92, P. 105325 - 105325

Published: Dec. 30, 2023

Language: Английский

Citations

3